Worsening of asthma control after COVID-19

BACKGROUND: SARS-CoV-2 enters lung cells via angiotensin-converting enzyme 2 (ACE2) receptor. Several studies suggest that interleukin-13, an important cytokine involved in T2 inflammation, reduces ACE2 expression, and therefore, asthma would not be a significant risk factor for the development of s...

Descripción completa

Detalles Bibliográficos
Autores principales: Agondi, Rosana Câmara, Menechino, Natália, Marinho, Ana Karolina Barreto Berselli, Kalil, Jorge, Giavina-Bianchi, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524244/
https://www.ncbi.nlm.nih.gov/pubmed/36186769
http://dx.doi.org/10.3389/fmed.2022.882665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524244/
https://www.ncbi.nlm.nih.gov/pubmed/36186769
http://dx.doi.org/10.3389/fmed.2022.882665

Ejemplares similares